Contact hypersensitivity (CHS) is a common skin disease induced by epicutaneous sensitization to haptens. Conflicting results have been obtained regarding pathogenic versus protective roles of mast cells (MCs) in CHS, and this has been attributed in part to the limitations of certain models for studying MC functions in vivo. Here we describe a fluorescent imaging approach that enables in vivo selective labeling and tracking of MC secretory granules by real-time intravital 2-photon microscopy in living mice, and permits the identification of such MCs as a potential source of cytokines in different disease models. We show using this method that dermal MCs release their granules progressively into the surrounding microenvironment, but also represent an initial source of the antiinflammatory cytokine IL-10, during the early phase of severe CHS reactions. Finally, using 3 different types of MC-deficient mice, as well as mice in which IL-10 is ablated specifically in MCs, we show that IL-10 production by MCs can significantly limit the inflammation and tissue pathology observed in severe CHS reactions.
Introduction
One important function of the immune system is to restrain the tissue pathology that can occur during severe inflammatory reactions. Mast cells (MCs) are widely deployed at host-environment interfaces (e.g., the skin or mucosae) and can be activated to secrete diverse products, including some with antiinflammatory or immunosuppressive functions, in response to a variety of different stimuli (1) (2) (3) (4) (5) . MCs therefore can represent both powerful sentinels of the immune system and potential sources of products which might limit inflammation or its associated tissue injury.
However, whether MCs actually perform antiinflammatory or immunosuppressive functions in vivo is controversial. We proposed, based on experiments performed in mice with a profound MC deficiency related to abnormalities in Kit structure or expression (referred to herein as "Kit-mutant MC-deficient mice"), that MCs and MC production of IL-10 can limit skin pathology during severe contact hypersensitivity (CHS) reactions (6) . As noted in that study, it has been appreciated for some time that Kit-mutant mice have several phenotypic abnormalities in addition to their MC deficiency, and subsequently we and others generated Kit-independent MC-deficient mouse strains that are deficient in MC populations due to genetic manipulations independent of alterations in Kit (7) (8) (9) (10) (11) (12) .
Using one Kit-independent MC-deficient strain, Dudeck et al. reported evidence that MCs amplify rather than limit CHS responses, and concluded that the exaggerated CHS reactions observed in Kit-mutant animals are not caused by the absence of MCs but instead reflect other effects of the KIT deficiency (7, 13) . By contrast, based on findings in both Kit-mutant and Kit-independent MC-deficient mice, Gimenez-Rivera et al. recently reported that MCs can suppress skin inflammation in a new mouse model of chronic CHS (14) .
To help resolve the apparent controversy about whether MCs and MC-derived IL-10 indeed can function to suppress severe acute CHS, we developed a new imaging method that permits the unambiguous Contact hypersensitivity (CHS) is a common skin disease induced by epicutaneous sensitization to haptens. Conflicting results have been obtained regarding pathogenic versus protective roles of mast cells (MCs) in CHS, and this has been attributed in part to the limitations of certain models for studying MC functions in vivo. Here we describe a fluorescent imaging approach that enables in vivo selective labeling and tracking of MC secretory granules by real-time intravital 2-photon microscopy in living mice, and permits the identification of such MCs as a potential source of cytokines in different disease models. We show using this method that dermal MCs release their granules progressively into the surrounding microenvironment, but also represent an initial source of the antiinflammatory cytokine IL-10, during the early phase of severe CHS reactions. Finally, using 3 different types of MC-deficient mice, as well as mice in which IL-10 is ablated specifically in MCs, we show that IL-10 production by MCs can significantly limit the inflammation and tissue pathology observed in severe CHS reactions.
monitoring, in dermal MCs in vivo, of both changes in their cytoplasmic secretory granules and activation of Il10 gene transcription. In contrast to approaches employing genetically encoded cell tracers, which usually require breeding of the reporter mice with other strains to achieve cell-specific expression of the tracer, our new tunable fluorescent imaging approach can (a) be employed regardless of mouse strain, (b) enable in vivo selective labeling of MC secretory granules for prolonged time periods, and (c) permit longitudinal monitoring of such labeled MCs in vivo by noninvasive intravital 2-photon microcopy.
Using this new in vivo imaging method, we monitored simultaneously both MC granule secretion dynamics and MC activation of transcription of the Il10 gene in our model of 1-fluoro-2,4-dinitrobenzeneinduced (DNFB-induced) severe CHS. We show that dermal MCs secrete intracellular granule content into the surrounding microenvironment a few hours after epicutaneous DNFB challenge, and that MCs also represent one of the first immune cells to exhibit Il10 gene activation at such sites. Finally, using 2 different strains of Kit-independent MC-deficient mice, as well as mice in which IL-10 is specifically ablated in MCs, we confirmed that MCs, and MC-derived IL-10, can significantly limit both the inflammation and the tissue pathology observed in severe CHS reactions.
Results
In vivo labeling and imaging of dermal MC cytoplasmic granules. We recently reported a method to visualize the spatiotemporal features of MC granule structures once they have been exteriorized during MC degranulation in vivo: intradermal (i.d.) injection of fluorochrome-labeled avidin (sulforhodamine 101-coupled avidin [Av.SRho]) into the ear pinna dermis 10 to 30 minutes before performing 2-photon microscopy (15) . During MC degranulation, which results in fusion of secretory granule membranes with the plasma membrane (16, 17) , externalized granule matrices are rapidly bound by soluble fluorescent Av.SRho probe present in the microenvironment, allowing imaging by high-resolution confocal and in vivo 2-photon microscopy of such exteriorized granule structures (15, 18) . While this method is useful for identifying exteriorized MC granule structures, it requires (a) that MCs are activated to degranulate, and (b) using specific MC reporter mice (e.g., Mcpt5-EYFP mice; see refs. 7, 19) to identify nondegranulated MCs in the dermis prior to their activation (therefore limiting the use of other reporter animal models encoding fluorescent tracers of comparable excitation/emission spectra).
To bypass these limitations, we investigated whether long-term exposure (i.e., days to months) to fluorochrome-labeled avidin in vivo would result in uptake of the probe and specific labeling of intracellular secretory granules of dermal MCs under homeostatic conditions. Seven days after performing single i. Figure 1A ; supplemental material available online with this article; https://doi.org/10.1172/jci. insight.92900DS1), which is highly expressed at the MC surface (22) .
To Figure 1E ), and analyzed the spatial overlap of Av.SRho and EYFP fluorescence signals employing high-resolution 3D single-cell 2-photon imaging, as previously described (15) . We observed an almost complete spatial overlap of the 2 fluorescent signals ( Figure 1F ). When fluorescence overlap was quantified at the single-cell level in the Av.SRho-injected area, we confirmed that ~90% of EYFP MC granules is likely due to the presence in the granules of high levels of negatively charged proteoglycans (e.g., heparin), to which avidin can strongly bind (18, 23, 24) , as well as to the low pH of MC granules, which might protect the avidin probe from protease-mediated degradation (25) . Taken together, these results demonstrate that a single i.d. injection of fluorochrome-labeled avidin results in highly selective labeling of the cytoplasmic granules of dermal MCs, thus enabling their visualization by noninvasive intravital microscopy in living mice for a prolonged period of time.
Granule-associated avidin does not interfere with MC degranulation or MC-dependent PCA reactions.
Avidin molecules have a strong affinity for highly negatively charged molecules in MC secretory granules, e.g., heparin (26) . We therefore investigated whether incorporation of fluorochrome-labeled avidin could interfere with MC degranulation, the release of granule-associated mediators, or the induction of classical MC-dependent allergic inflammation at sites of IgE-dependent passive cutaneous anaphylaxis (PCA). We incubated in vitro bone marrow-derived cultured MCs (BMCMCs) with Av.SRho for 4 days (the time required to observe substantial incorporation of Av.SRho into their secretory granules [Supplemental Figure 1C] ) and measured the quantity of β-hexosaminidase release (27) in their supernatants upon IgE/Ag challenge. While we barely detected the presence of β-hexosaminidase in supernatants of nonstimulated control BMCMCs, we measured comparable quantities of the enzyme in the supernatants of Av.SRho -or Av.SRho + BMCMCs stimulated with IgE/Ag (Supplemental Figure 1D ). We also examined IgE-dependent PCA reactions (28) to assess whether the incorporation of Av.SRho into the cytoplasmic granules of dermal MCs might influence either antigen-induced MC degranulation or 2 of the MC-dependent features of such reactions: (a) local tissue swelling, or (b) infiltration of immune cells into the ear pinna. We used noninvasive 2-photon microscopy to monitor simultaneously the release of MC cytoplasmic granules and the associated changes in local blood flow (by measuring changes in fluorescence intensity in the interstitial space in mice injected i.v. with dextran-FITC; see refs. 15, 20) upon induction of IgE-mediated PCA. In mice injected with vehicle, little or no MC activation was observed and minimal amounts of dextran-FITC extravasation were detected in the interstitial space ( Figure 2A and Supplemental Video 1). In agreement with our recent report describing the dynamics of MC responses upon their activation by different stimuli (15) , induction of an IgE-mediated PCA reaction was associated with the delayed (starting ~15 minutes after challenge) but progressive release of Av.SRho + cytoplasmic secretory granules, some of which then appeared to be transported further within the tissue matrix ( Figure  2A and Supplemental Video 2). In accord with this observation, we also measured a relatively slow (also starting ~15 minutes after challenge) but progressive extravasation of dextran-FITC, with the highest levels detected in the interstitial space ~25 minutes after induction of the reaction ( Figure 2 , A and B, and Supplemental Video 2). Interestingly, we noticed that the extravasation of dextran-FITC always started prior to the detection of exteriorized Av.SRho + granule structures ( Figure 2B ). These data are consistent with current understanding that histamine, which can augment vascular permeability, is one of the first cytoplasmic granule-associated mediators released upon MC activation.
We next measured the swelling elicited during reactions induced in both the vehicle-infused (Av.SRho Figure 2C ). Challenge with DNP-HSA induced strong ear swelling, with the highest levels at 30 minutes after challenge and requiring ~6 hours to resolve fully ( Figure 2C ). We detected similar levels of ear swelling at all time points was injected retro-orbitally 30 minutes before imaging to label blood vessels. Representative 3D photographs of the ear pinna showing merged fluorescence of Av.SRho (red), dextran-FITC (green), and collagen structures (blue Mean + SEM, 2-tailed, unpaired t test, **P < 0.01; ***P < 0.001; ****P < 0.0001. Data (n = 3 mice per group) are pooled from the 3 experiments performed (each done with 1 mouse per group), each of which gave similar results; circles show values for individual mice. Scale bars: 100 μm. up to 6 hours after challenge in both Av.SRho + and Av.SRho -ear pinnae ( Figure 2C ). Moreover, histological analyses revealed similar levels of MC degranulation and leukocyte infiltration in ear pinnae 6 hours after challenge regardless of the presence or absence of Av.SRho (Figure 2, D-F) .
Taken together, these results indicate that the features of the IgE-and MC-dependent vascular responses and tissue inflammation we analyzed, which are thought to depend, at least in part, on the activities of mediators prestored in the cytoplasmic granules of MCs (29-32), were not substantially altered by the presence of fluorochrome-labeled avidin. These findings support the conclusion that i.d. injection of fluorochrome-labeled avidin not only represents an easy and fast way to label dermal MC secretory granules for their monitoring in vivo, but also will enable studies of MC degranulation in vivo in different disease models and, in principle, regardless of the mouse's genetic background.
Intravital monitoring of MC degranulation and activation of Il10 gene transcription during CHS reactions.
We next used our intravital imaging method to analyze, over time in the same animals, the spatiotemporal characteristics of MC degranulation and activation of Il10 gene transcription in severe CHS reactions in situ (Supplemental Figure 2A) . We first injected Av.SRho i.d. into the ear pinnae of Mcpt5-EYFP mice (as described in Figure 1 , A, E, and F) to monitor MC granule release over time at the site of CHS and to discriminate unambiguously Av.SRho + degranulated MCs from other cell types that potentially could have taken up free exteriorized Av.SRho + granules (e.g., dermal dendritic cells). Before DNFB challenge (day 0), only ~10% of dermal MCs were marginally degranulated, exhibiting just a few Av.SRho + granules outside of the cell ( Figure 3 , A and C). However, as early as 1 day after DNFB challenge, ~60% of dermal MCs were extensively degranulated and this number reached ~90% at day 2 ( Figure 3, A and C) . Even though MCs were strongly degranulated at 2 and 3 days after DNFB challenge, most of the cells detected as strongly positive for Av.SRho in the analyzed areas were still identifiable as EYFP + dermal MCs ( Figure 3A ). We then injected Av.SRho i.d. into ear pinnae of IL-10-GFP mice expressing a GFP tracker under the control of the Il10 promoter (33), to monitor simultaneously over time both MC secretory granules and activation of Il10 gene transcription. Before DNFB challenge (day 0), no Av.SRho + dermal MCs were positive for GFP, suggesting that, at least under these baseline conditions, the Il10 gene was not substantially activated ( Figure 3, B and C) . However, we detected a clear GFP signal (i.e., emission of green fluorescence detectable above the green autofluorescence of the dermis) in ~40% of Av.SRho + MCs as soon as 1 day after DNFB challenge, a percentage that remained stable for the next 2 days (Figure 3 , B and C). We next quantified the total number of IL-10-GFP + cells at sites of CHS, and how many of these cells were Av.SRho + MCs. We observed a progressive increase over time in the total number of IL-10-GFP + cells (with the highest numbers 2 days after DNFB challenge) (Figure 3, B and D) , a finding which is consistent with previous reports describing the kinetics of infiltration of Treg cells at sites of CHS (34) . Notably, IL-10-GFP + Av.SRho + dermal MCs represented up to ~55% of all detected IL-10-GFP + cells at day 1, but only ~10%-20% at days 2 and 3 after DNFB challenge (Figure 3 , B, D, and E). Taken together, these results suggest that dermal MCs are one of the first immune cells to produce IL-10 at sites of severe CHS, before the substantial infiltration of other IL-10-producing immune cells.
Evidence that MCs and MC-derived IL-10 limit features of severe CHS reactions. We next used genetic approaches to reassess the roles of MCs and MC-derived IL-10 in this model of severe CHS (Supplemental Figure 2A ). In accord with our previous report (6) , Kit W-sh/W-sh MC-deficient mice exhibited greater ear swelling than their respective MC-sufficient littermate controls in this model (Supplemental Figure  2, -way ANOVA, (C, E, and F) 2-tailed, unpaired t test (in C, red and black asterisks represent significance of differences between data depicted by red or black circles vs. open circles, respectively). Data (n = 3-12 mice per group) are pooled from the 3 independent experiments performed (each done with n = 1-4 mice per group), each of which gave similar results. *P < 0.05; **P < 0.01; ***P < 0.001. ns, not significant. Figure 5 , B, C, and E). Notably, the enhancement of both the tissue swelling and the epidermal thickness associated with the reactions observed in Mcpt5-Cre + ; Il10 fl/fl mice was less pronounced than that observed in the Kit-independent MC-deficient mice, suggesting that MCs might help to limit these features of this acute model of severe CHS by both IL-10-dependent and IL-10-independent mechanisms.
Taken together, these results indicate that MCs, and MC-derived IL-10, can help to limit the tissue changes associated with this model of severe CHS.
Discussion
In this study, we demonstrate the utility of a simple, fast, and inexpensive new in vivo imaging method that allows longitudinal intravital monitoring of the storage, release, and movement of MC secretory granules during immune responses, as exemplified here using both PCA and CHS models. Because this imaging method is based on the uptake of the fluorescent reporter, Av.SRho, by living dermal MCs and its long-term storage in their secretory granules, it can be used in mice of any genotype (as long as their MCs have secretory granules containing heparin or other highly negatively charged proteoglycans). This greatly increases the utility of this new imaging method compared with creating mouse strains in which fluorescent reporters are expressed in MCs based on genetic mechanisms.
By combining this new imaging method with genetic approaches, we provide additional evidence that MCs, and MC-derived IL-10, can help to limit the inflammation and other pathology at sites of severe hapten-induced CHS reactions. Notably, in a different disease setting, and using both Kit W-sh/W-sh mice and
fl/fl mice, Chan et al. (38) provided evidence that MC production of IL-10 can suppress humoral and cell-mediated responses and enhance bacterial persistence in a mouse model of bladder infection with E. coli. The findings of Chan et al. (38) thus indicate that MC production of IL-10 also can contribute to suppression of inflammation in sites other than the skin.
However, we thought it was important to try to understand the possible reason(s) for the discrepancies between our results (obtained here and in our previous study; see ref. 6 ) and the results reported by ; DTA + (MC-sufficient, black) mice. Scale bars: 200 μm. Mean ± SEM; **P < 0.01; ***P < 0.001; (B) 2-way ANOVA; (D and E) 2-tailed, unpaired t test. Data (n = 6-12 mice per group) are pooled from the 3 independent experiments performed (each done with n = 2-4 mice per group), each of which gave similar results. ns, not significant.
Taken together, our results help to reconcile the findings reported by Grimbaldeston et al. (6) and Dudeck et al. (7) by providing additional evidence that MCs can either amplify or limit the features of CHS reactions, depending on the severity of the model of CHS tested. Notably, Dudeck et al. (7) reported that, in models of CHS whose severity based on ear swelling measurements were intermediate between the severe and mild models of acute CHS used in the present study, MCs were important promoters of CHS. The responses to the haptens were weaker in MC-deficient Mcpt5-Cre + ; DTA mice than in the corresponding MC-sufficient control mice, while the opposite result was obtained in MCdeficient Kit W-sh/W-sh mice. Also in the present study, we found that MCs can promote CHS of mild intensity, as the inflammatory response in the Kit-independent Cpa3-Cre + ; Mcl-1 fl/fl MC-deficiency model was strongly reduced. It is possible that, for certain CHS reactions of moderate intensity, such proinflammatory MC functions may be concealed in Kit-mutant models by mechanisms of suppression of CHS that are KIT related but MC independent. Nevertheless, in contrast to the CHS-promoting MC functions observed in lower intensity CHS reactions, we report herein that in the severe model of DNFB-induced CHS used by Grimbaldeston et al. (6) a negative regulatory role for MCs and MC-derived IL-10 can be observed in mice that lack abnormalities of Kit structure or expression, including in the same mouse strains that were employed by Dudeck et al. in their report (7). Mean ± SEM; *P < 0.05; **P < 0.01; ***P < 0.001; (B) 2-way ANOVA; (D and E) 2-tailed, unpaired t test. Data (n = 6-12 mice per group) are pooled from the 3 independent experiments performed (each done with n = 2-4 mice per group), each of which gave similar results.
Methods

Study approval
All animal care and experimentation was conducted in compliance with the guidelines of the NIH and with the specific approval of the Institutional Animal Care and Use Committees of Stanford University. tm1(DTA)Lky /J (ROSA-DTA) mice were obtained from Jackson Laboratories and bred at the Stanford University Research Animal Facility. We used age-matched mice of both sexes for the experiments, unless otherwise specified.
Mice
Reagents DNP-HSA (catalog A6661), DNFB (catalog D1529), olive oil (catalog O1514), Av.SRho (catalog A2348), dextran-FITC (catalog 46945), Triton X-100 (catalog T8787), and poly-D-lysine (catalog P6407) were all from Sigma-Aldrich. DNP-specific IgE antibodies (clone ε-26) were provided by FuTong Liu (UC Davis, Davis, California, USA). Anti-KIT-Alexa Fluor 647 (A647) (clone 2B8, catalog 105818) was obtained from Biolegend. Nunc Lab-Tek 1.0 borosilicate cover glass system 8 chambers (catalog 155411) were from Thermo Fisher Scientific.
CHS models
Severe CHS model. We used the severe DNFB-induced model of CHS as described by Grimbaldeston et al. (6) and in Supplemental Figure 2A . Mice were sensitized on the shaved abdomen with 30 μl of 0.5% (vol/ vol) DNFB in a vehicle of 100% acetone. At 5 days after sensitization, mice were challenged with 20 μl of vehicle (100% acetone) alone to 1 ear (10 μl to each side) and 0.2% (vol/vol) DNFB (in 100% acetone) to the other ear (10 μl to each side).
Mild CHS model. In the experiments described in Supplemental Figures 3 and 4 , we used a more mild CHS model. Mice were sensitized on the shaved abdomen with 30 μl of 0.2% (vol/vol) DNFB in a vehicle of 100% acetone. At 5 days after sensitization, mice were challenged with 20 μl of vehicle (acetone/olive oil, 4:1) alone to 1 ear (10 μl to each side) and 0.1% (vol/vol) DNFB (in acetone/olive oil, 4:1) to the other ear (10 μl to each side).
In both models of CHS, ear thickness was measured before and at several intervals after hapten challenge with a micrometer (Ozaki MFG). Toluidine blue and H&E staining of histological sections of ear pinnae were performed as described in the supplemental methods section.
Statistics
Statistical tests were performed with PRISM 6 (GraphPad). Two-tailed Student's t test (unpaired or paired) and 2-way ANOVA tests were performed as noted in the respective figure legends. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001; ns, not significant (P > 0.05).
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